E F Vonesh

Summary

Affiliation: Baxter Healthcare Corporation
Country: USA

Publications

  1. ncbi request reprint Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis
    E F Vonesh
    Baxter Healthcare Corporation, Applied Statistics Center, Round Lake, Illinois 60073, USA
    J Am Soc Nephrol 10:354-65. 1999
  2. ncbi request reprint The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis
    Edward F Vonesh
    Baxter Healthcare Corporation, Applied Statistics Center, Round Lake, Illinois 60073, USA
    Kidney Int 66:2389-401. 2004
  3. ncbi request reprint Modeling of icodextrin in PD Adequest 2.0
    Edward F Vonesh
    Statistics, Epidemiology and Surveillance, Baxter Healthcare Corporation, Route 120 and Wilson Road, Round Lake, Illinois 60073, USA
    Perit Dial Int 26:475-81. 2006
  4. ncbi request reprint Shared parameter models for the joint analysis of longitudinal data and event times
    Edward F Vonesh
    Baxter Healthcare Corporation, Round Lake, IL 60073, USA
    Stat Med 25:143-63. 2006
  5. ncbi request reprint Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model
    W R Clark
    Renal Division, Baxter Healthcare Corporation, McGaw Park, Illinois 60085, USA
    J Am Soc Nephrol 10:601-9. 1999
  6. ncbi request reprint Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    J Am Soc Nephrol 15:174-9. 2004
  7. ncbi request reprint The effect of technique failure on outcome in black patients on continuous ambulatory peritoneal dialysis
    George C Kim
    Department of Medicine, Rush Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
    Perit Dial Int 22:53-9. 2002
  8. ncbi request reprint Body size and outcomes on peritoneal dialysis in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 64:1838-44. 2003
  9. ncbi request reprint The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation
    Mohamed Suliman
    Renal Medicine and Baxter Novum, K56, Karolinska University Hospital Huddinge, Karolinska Institutet, S 141 86 Stockholm, Sweden
    Nephrol Dial Transplant 22:209-17. 2007

Detail Information

Publications9

  1. ncbi request reprint Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis
    E F Vonesh
    Baxter Healthcare Corporation, Applied Statistics Center, Round Lake, Illinois 60073, USA
    J Am Soc Nephrol 10:354-65. 1999
    ..Additional incident-based studies that allow for additional case-mix adjustments are needed to better compare outcomes between HD and PD...
  2. ncbi request reprint The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis
    Edward F Vonesh
    Baxter Healthcare Corporation, Applied Statistics Center, Round Lake, Illinois 60073, USA
    Kidney Int 66:2389-401. 2004
    ..This study was undertaken to identify key patient characteristics for which the risk of death differs by dialysis modality...
  3. ncbi request reprint Modeling of icodextrin in PD Adequest 2.0
    Edward F Vonesh
    Statistics, Epidemiology and Surveillance, Baxter Healthcare Corporation, Route 120 and Wilson Road, Round Lake, Illinois 60073, USA
    Perit Dial Int 26:475-81. 2006
    ..To validate the use of a modified three-pore model for predicting fluid transport during long dwell exchanges that use a 7.5% icodextrin solution...
  4. ncbi request reprint Shared parameter models for the joint analysis of longitudinal data and event times
    Edward F Vonesh
    Baxter Healthcare Corporation, Round Lake, IL 60073, USA
    Stat Med 25:143-63. 2006
    ..The model and methods are illustrated using data from a multi-centre study of the effects of diet and blood pressure control on progression of renal disease, the modification of diet in renal disease study...
  5. ncbi request reprint Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model
    W R Clark
    Renal Division, Baxter Healthcare Corporation, McGaw Park, Illinois 60085, USA
    J Am Soc Nephrol 10:601-9. 1999
    ..A daily low-flow/long-time regimen substantially increases the effective removal of all solutes...
  6. ncbi request reprint Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    J Am Soc Nephrol 15:174-9. 2004
    ..Hemoglobin levels in U.S. hemodialysis and peritoneal populations are similar. However, erythropoietin doses are dramatically higher in hemodialysis patients...
  7. ncbi request reprint The effect of technique failure on outcome in black patients on continuous ambulatory peritoneal dialysis
    George C Kim
    Department of Medicine, Rush Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
    Perit Dial Int 22:53-9. 2002
    ..0001). The purpose of this study was to determine the effect of technique failure/transfer to hemodialysis (HD) on patient survival in black PD patients...
  8. ncbi request reprint Body size and outcomes on peritoneal dialysis in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 64:1838-44. 2003
    ..Being overweight is often cited as a relative contraindication to peritoneal dialysis. Our primary objective was to determine whether actual mortality rates support this opinion...
  9. ncbi request reprint The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation
    Mohamed Suliman
    Renal Medicine and Baxter Novum, K56, Karolinska University Hospital Huddinge, Karolinska Institutet, S 141 86 Stockholm, Sweden
    Nephrol Dial Transplant 22:209-17. 2007
    ..The aim of this study was to examine whether the inverse association maintains, mitigates or reverses after comprehensive multivariate adjustment for the presence of wasting and inflammation as well as other potential confounders...